AVINOR TRI-NH9A
AVINOR TRI-NH9A
Triple Inactivated Vaccine
(Newcastle Disease + H9 Avian Influenza + Avian Adenovirus)
(Norwich Animal Health)
Generic Name
Triple Inactivated Vaccine of Newcastle Disease Virus, H9 Subtype Avian Influenza Virus and Group I Avian Adenovirus
Description
AVINOR TRI-NH9A is a triple inactivated oil-emulsion vaccine containing:
Inactivated Newcastle Disease Virus (NDV)
Inactivated H9 subtype Avian Influenza Virus (H9 AIV)
Inactivated Group I Avian Adenovirus
The vaccine is formulated to provide broad and long-lasting protection against major viral diseases affecting chickens.
Indication
AVINOR TRI-NH9A is indicated for the active immunization of chickens to prevent:
Newcastle Disease (ND)
H9 subtype Avian Influenza
Group I Avian Adenovirus infection
Target Species
Chickens (broilers, layers, breeders)
Administration and Dosage
Administer by subcutaneous injection in the neck or intramuscular injection.
Dosage
Chicks within 3 weeks of age:
0.3 ml per birdChickens over 3 weeks of age:
0.5 ml per bird
Vaccination Program
Single vaccination according to age
Booster vaccination may be applied based on field challenge and veterinary recommendation
Method of Use
Allow vaccine to reach room temperature before use
Shake well to ensure a uniform emulsion
Use sterile syringes and needles
Do not mix with other vaccines or medicinal products
Contraindications
Do not vaccinate sick, stressed, or immunocompromised birds
Hypersensitivity to any component of the vaccine
Warnings and Precautions
For veterinary use only
Vaccinate healthy birds only
Avoid freezing
Follow strict biosecurity measures during vaccination
Dispose of empty containers according to regulations
Adverse Reactions
Mild and transient swelling at the injection site may occur
Reactions usually resolve spontaneously
Withdrawal Period
None
Storage
Store at 2–8°C
Do not freeze
Protect from light
Shelf Life
As stated on the label when stored under recommended conditions
Packaging
Multidose vials (e.g. 100 ml, 250 ml, 500 ml)